In a significant stride for the aesthetics industry, Miria, a cutting-edge laser system, has made its entrance with the coveted clearance from the U.S. Food and Drug Administration (FDA). This innovative technology addresses a prevalent challenge with energy devices—ensuring safety and efficacy across diverse skin tones.
Miria sets itself apart by delivering light into specific skin layers through a cone-shaped approach, offering providers the flexibility to choose between superficial, medium, and deep treatments. This precision enables targeted energy delivery to the desired area while bypassing top skin layers, minimizing the risk of overheating, burns, and post-inflammatory hyperpigmentation. The device incorporates a “zoom lens” with 10x magnification, allowing providers to observe minute details that may escape the naked eye. Additionally, Miria features an artificial intelligence (AI) system that learns about each patient’s skin, adapting treatments accordingly.
Addressing a spectrum of concerns such as sun damage, textural issues, acne scarring, deep wrinkles, and volume loss, Miria stands out for its versatility. Dr. Marina Peredo, a board-certified dermatologist in New York City and an early adopter of Miria, commended its unique capabilities, stating, “Miria can treat multiple issues in one session and with one device. Because it has the ability to go to greater depths, it can treat higher volumes of tissue in a single treatment. Anyone suffering from sun damage, rosacea, and other mild conditions up to more serious concerns including acne scarring, volume loss, and deep wrinkles is a candidate for Miria.” This breakthrough technology signifies a promising advancement in the realm of aesthetic treatments.
